Table 4.
Key Genetic Variants in Allergic Rhinitis Susceptibility
| Gene/Locus | Variant/SNP | Function/Association Description | Reference |
|---|---|---|---|
| ZNF608 | Not specified | A key risk gene for house dust mite-induced AR | 80 |
| Near CD28 | Not specified | Novel locus specific to East Asian populations | 81, 82 |
| 9q32 | Not specified | Novel pleiotropic region | 81, 82 |
| 10q25.2 | Not specified | Novel pleiotropic region | 81, 82 |
| CLEC16A | Not specified | Variants confer a decreased risk of AR, playing a protective role | 83 |
| Multiple Genes | Not specified | AR shares over 100 risk genes with asthma and eczema | 78 |
| Not specified | rs9565267 | Associated with the specific trajectory from atopic dermatitis (AD) to AR development | 84 |
| HLA region | Not specified | AR is a causal risk factor for food allergy, linked through shared loci in the HLA region | 85 |
| GSDMB | Not specified | Gene polymorphisms show a stronger association with asthma and asthma-comorbid AR than with AR alone | 79 |
| HLA region | Not specified | One of the strongest susceptibility loci for AR | 86 |
| HLA-DQB1, HLA-B | Amino acid variants | Risk signal directly correlated with specific amino acid variants in the peptide-binding pocket, affecting allergen presentation efficiency | 86 |
| HLA region | rs7775228 | Significantly associated with AR risk in Chinese Han population, with the risk allele linked to increased total serum IgE levels | 87 |
| HLA, TYRO3 | Not specified | Interaction explored to comprehensively understand the pathogenic mechanism of AR | 88 |
| FLG | Loss-of-function (LoF) mutations | The strongest genetic risk factor for AD; increases risk of subsequent AR and asthma by disrupting barrier integrity | 89 |
| FLG | Not specified | Mutations primarily lead to early eczema, promoting aeroallergen sensitization, ultimately causing AR and asthma | 90 |
| FLG | Not specified | May have a direct effect on rhinitis at age 10 independent of eczema, suggesting a potential role in the nasal mucosal barrier | 90 |
| FLG | Not specified | Common LoF mutations in European populations | 91 |
| FLG | Not specified | Extremely rare and not significantly associated with disease in Turkish children | 92 |
| FLG | Specific mutations | Specific mutation types identified in African American and Saudi populations, associated with AR and other allergic diseases | 89, 93 |
| FLG | Not specified | Poor maternal diet during pregnancy confers a risk comparable to the genetic risk of carrying FLG mutations, highlighting the key role of impaired epithelial barrier function | 94 |
| TSLP | rs3806933 | Significantly associated with AR risk in Korean population; a key genetic risk driving the "atopic march" | 98 |
| TSLP | rs2289277 | The risk allele [C] significantly increases the likelihood of developing multiple concurrent allergic diseases | 99 |
| TLR3 | Not specified | Variants directly associated with aeroallergen sensitization; TLR3 signaling can induce TSLP expression | 100 |
| IL4R | I50V (rs1805010), Q576R (rs1801275) | Functional missense mutations significantly associated with atopy risk | 97 |
| IL4R | rs1801275 | Interaction with allergy history analyzed in the context of allergy and childhood leukemia | 101 |
| FLG, IL4R | rs3024676 | FLG LoF mutations significantly increase the risk of allergic sensitization only in individuals homozygous for the IL4R SNP rs3024676 | 102 |
| STAT6 | rs324011 | TT homozygous genotype significantly associated with increased risk of allergic asthma and elevated total serum IgE levels | 96 |
| IL33, IL1RL1 | Rare variants | Exome sequencing identifies this region as one of the strongest gene clusters associated with asthma and allergy | 95 |
| IL33 | rs1342326 | Variant genotype significantly associated with AR risk in school-aged children, adjusted OR=3.23 | 103 |
| IL33 | rs4742170 | The risk 'T' allele disrupts the glucocorticoid receptor (GR) binding site, weakening its suppression of IL33 expression | 104 |
| TSLP, IL-33 | Not specified | Both play roles in allergic inflammation; TSLP is an important upstream regulator of IL-13 | 105 |
| FCER1G | rs36233990 | Significantly enriched in patients with AR comorbid with asthma, directly linking genetic variation to the core effector phase of AR | 106 |